REBLOZYL subst seche 25 mg 1x25mg pce

7680695920017 CH-69592 B03XA06 06.07.3.

No images available

Details

Product number
6959201
CPT
-
Packaging group
1 x 25 mg
Unit
Durchstechflasche(n)
Composition
luspaterceptum 25 mg, acidum citricum monohydricum, natrii citras dihydricus, polysorbatum 80, saccharum, acidum hydrochloridum, natrii hydroxidum, pro vitro corresp. natrium max. 0.5 mg.

Articles (1)

Reblozyl 25 mg, Pulver zur Herstellung einer Injektionslösung
Pulver
1 x 25 mg
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
09/07/2026
Professional SmPC
Français
09/07/2026
Professional SmPC
Italien
09/07/2026

Detailed composition

Substance Quantity Type Category
luspaterceptum
25.0 MG Substance Wirkstoff (Principe actif)
acidum citricum monohydricum
- Substance HNIDK
natrii citras dihydricus
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
saccharum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
natrium
- Substance HBESI

Authorization holder

Bristol-Myers Squibb SA

6312 Steinhausen

Authorization information

Swissmedic authorization number
69592
Drug name
Reblozyl, Pulver zur Herstellung einer Injektionslösung
Galenic form
PULVL
ATC Code
B03XA06
Authorization status
Z
Dispensation category
A
First authorization
21/05/2026
Authorization expiration date
20/05/2031
IT number
06.07.3.
Domain
Human medicine
Field of application
Myelodysplastische Syndrome, β-Thalassämie

Packaging details

Description (FR)
REBLOZYL subst seche 25 mg 1x25mg pce
Description (DE)
REBLOZYL Trockensub 25 mg 1x25mg Stk
Market launch
30/06/2026
Narcotic (BTM)
No

Other packaging sizes

REBLOZYL subst seche 75 mg 1x75mg pce
1 x 75 mg DUR
GTIN: 7680695920024
View
Buy us a coffee Explore the data